This inventor holds 2 USPTO granted patents. Top assignees: Jones Pharma, Inc., King Pharmaceutical Research & Development, Inc.. Active years: 2003-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 2 Years Active: 2003-2006
Title: The Innovations of Philip A DiMenna
Introduction
Philip A DiMenna is a notable inventor based in St. Petersburg, FL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized compositions for thyroid hormones. With a total of 2 patents, his work has had a meaningful impact on the pharmaceutical industry.
Latest Patents
DiMenna's latest patents include innovative formulations that enhance the stability and efficacy of pharmaceutical compositions. One of his key inventions is a stabilized pharmaceutical and thyroid hormone composition, which features a pharmaceutical composition with β-sheet microcrystalline cellulose. This formulation is designed to improve potency life and includes methods of preparation. Another significant patent focuses on levothyroxine compositions, which relate to stable pharmaceutical compositions containing active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium. These compositions are preferably in an immediate release solid dosage form, providing methods for making and administering these stabilized formulations.
Career Highlights
Throughout his career, DiMenna has worked with reputable companies in the pharmaceutical sector. He has been associated with Jones Pharma, Inc. and King Pharmaceutical Research & Development, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
DiMenna has collaborated with several professionals in his field, including G Andrew Franz and Elaine A Strauss. These collaborations have likely enriched his research and development efforts, leading to the successful patents he holds today.
Conclusion
Philip A DiMenna's contributions to pharmaceutical innovations, particularly in thyroid hormone compositions, demonstrate his commitment to improving medication stability and efficacy. His patents reflect a deep understanding of pharmaceutical science and a dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile